Graphomotor Intervention Program for Handwriting Difficulties Prevention in Preschool Age
Launched by UNIVERSITY OF ÉVORA · Oct 5, 2018
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
According to estimates, 12 to 30% of children have handwriting difficulties (1), which has negative consequences for school success (2). In addition, this is one of the main reasons for referral and consultation in psychomotricity in school-age (3), which reflects the urgency of acting in this field.
The need for prevention and early intervention is indisputable (4). Several studies indicate that both outweigh the benefits of late intervention, because as time goes on it is increasingly difficult to correct handwriting difficulties (5-6).
Graphomotor skills include the trait, the drawing ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children in the last year of preschool education (aged 5 years old);
- • Participation agreement.
- Exclusion Criteria:
- • Diagnosed or suspected of neurological disabilities (e.g., cerebral palsy, epilepsy), psychiatric and/or behavioural disorders;
- • Presence of uncorrected vision and hearing problems;
- • Referenced by Special Education/National Service of Early Intervention in Childhood;
- • Native language is not Portuguese;
- • Children with direct intervention in graphomotor skills or who had a similar intervention to that proposed less than 1 year ago;
- • Participation in the intervention program of less than 80%;
- • Children undergoing drug therapy (e.g., antihistamines) that interfere with the study variables;
- • Do not wish to participate in the study.
About University Of évora
The University of Évora, a prominent institution in Portugal, is dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust academic resources and multidisciplinary expertise to facilitate cutting-edge research and development initiatives. Committed to enhancing patient care and contributing to scientific advancements, the University of Évora fosters collaborations with healthcare professionals and industry partners to conduct rigorous clinical trials that adhere to the highest ethical and regulatory standards. Through its research initiatives, the university aims to translate scientific discoveries into practical applications that benefit public health and improve therapeutic outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
évora, , Portugal
Patients applied
Trial Officials
Helena IF Coradinho, MSc
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials